Neuroreport · 1999 · 56 citations · 6 references
MedicineNeurosciencePharmacologyBehavioral NeuroscienceCognitive NeuroscienceNeuropharmacologyCentral Nervous System Drug ActionsCholinergic PharmacologyNeural Basis Of MemoryNeuromodulationWorking MemoryWorking Memory DeficitsAccuracyMuscarinic Receptor AntagonismMuscarinic ReceptorsNmda Receptor AntagonismNmda Receptor AntagonistsNmda Receptor PharmacologyNmda ReceptorsPrefrontal Cortex Function
We investigated the effects of NMDA and muscarinic acetylcholine receptor blockade in the rostral part of dorsomedial (dmPFC) and dorsolateral prefrontal cortex (dlPFC) on spatial working memory (SWM) (delayed non-matching to position task (DNMTP)). The NMDA antagonist, CPP (0.01, 0.03, 0.1 and 0.3 microg/hemisphere) and the muscarinic antagonist, scopolamine (10 microg/hemisphere) were locally infused into the brain of male Wistar rats. In the mPFC CPP 0.1 microg disrupted SWM delay-dependently and CPP 0.3 microg caused a delay-independent performance deficit. Scopolamine disrupted non-cognitive performance, but did not affect SWM accuracy. In the dlPFC, scopolamine or lower doses of CPP did not affect SWM accuracy, but CPP 0.3 microg disrupted non-cognitive performance. We concluded that the NMDA receptors in the dmPFC regulate SWM processes, whereas the muscarinic receptors in the dmPFC mediate non-cognitive performance in the DNMTP task.
6
Stephen B. Dunnett · Canadian Journal of Psychology/Revue Canadienne de Psychologie · 1990 · 121 citations
Medicine, Neurobiology, Neuroscience +17